Kiora Pharmaceuticals Inc. (KPRX) Live Share Price, Invest From India

Kiora Pharmaceuticals Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$2.61
Day's Price Range
$2.71
$2.53
-3.16%
Downside
7.11%
Upside
52 Week's Low
52 Week's High
$1.76
52-Week Price Range
$3.29
$2.53
30.26%
Downside
30.04%
Upside

Kiora Pharmaceuticals Inc. share price movements today

Previous Close: $2.57
Open: $2.65
Volume: 633.8K
Day's Low - High: $2.61 - $2.71
52 Week Low - High: $1.76 - $3.29

Kiora Pharmaceuticals Inc. Historical Returns

1 Month Return: + 0.4 %
3 Month Return: + 24.63 %
1 Year Return: -16.23 %
3 Year Return: -63.96 %
5 Year Return: 0 %

Kiora Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Kiora Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.8M

EPS (TTM)

-2.66

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-9.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-58.78%

Kiora Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kiora Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kiora Pharmaceuticals Inc.	BUY	$11.8M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Kiora Pharmaceuticals Inc. Stock including INR - Dollar returns

The Kiora Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Kiora Pharmaceuticals Inc. investment value today

Current value as on today

₹91,254

Returns

-₹8,746

(-8.75%)

Returns from Kiora Pharmaceuticals Inc. Stock

-₹16,225 (-16.23%)

Dollar Impact

₹7,480 (+7.48%)

Analyst Recommendation on Kiora Pharmaceuticals Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Kiora Pharmaceuticals Inc.. Average target price of $12

Kiora Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Kiora Pharmaceuticals Inc..

What analysts predicted

78.92%UPSIDE

Target Price

$12

Current Price

$2.53

Analyzed by

8 Analysts

Target

$12.00

Kiora Pharmaceuticals Inc. target price $12, a slight upside of 78.92% compared to current price of $2.53. According to 8 analysts rating.

Indian Investors' Interest in Kiora Pharmaceuticals Inc. Stock

Search interest for Kiora Pharmaceuticals Inc. Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 23, 2026 to June 22, 2026

Change:-32% versus previous 30 day period

Kiora Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	16	0	-	-15	-	-	-	-	-
Gross Profit	0	16	0	0	-15	0	0	0	0	0
Operating Income	-1	13	-2	-3	-2	-2	-2	0	-7	-2
EBITDA	-2	13	-2	-2	-2	-2	-2	-2	-5	-2
Interest Expense	0	-	-	-	0	-	-	-	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	13	-2	-3	-2	-2	-2	0	-7	-2
Income Tax Expense	0	0	0	-	2	0	0	0	0	-
Net Income	-2	13	-2	-3	-4	-2	-2	0	-6	-2
Net Profit Margin	-799.17%	84.08%	-11108.23%	0.00%	26.48%	0.00%	0.00%	0.00%	0.00%	0.00%

Kiora Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	1	2	0	0	-	-	16	-
Gross Profit	-7	-9	-6	2	-3	0	0	-4	16	0
Operating Income	-13	-14	-10	-7	-6	-14	-12	-12	4	-9
EBITDA	-13	-14	-10	-6	-7	-13	-13	-12	5	-12
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-13	-14	-10	-7	-6	-13	-13	-12	5	-12
Income Tax Expense	0	-1	0	0	0	0	0	0	2	-1
Net Income	-13	-13	-10	-7	-6	-13	-13	-12	3	-10
Net Profit Margin	-1993.76%	-3243.52%	-654.24%	-264.21%	-56901.65%	-114194.25%	0.00%	0.00%	22.47%	0.00%

Kiora Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	13	-2	-3	-4	-2	-2	0	-6	-2
Operating Cash Flow	13	-3	0	-2	-2	-3	-1	-2	-3
Investing Cash Flow	-	-21	-1	0	2	0	5	5	5
Financing Cash Flow	15	0	-	-	-	0	-	0	0
Change in Cash	28	-24	0	-1	0	-2	4	3	2

Kiora Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-13	-10	-7	-6	-13	-13	-12	3	-10
Operating Cash Flow	-6	-10	-8	-7	-10	-10	-9	8	-9
Investing Cash Flow	0	0	0	0	0	0	-	-22	14
Financing Cash Flow	10	11	3	4	17	8	5	15	0
Change in Cash	4	0	-4	-2	6	-1	-3	1	4

Global Institutional Holdings in Kiora Pharmaceuticals Inc.

Funds	Holdings
Advisor Group Holdings, Inc.	0%
Vanguard Group Inc	0.75%
Vanguard Capital Management, LLC	0.45%
DRW Securities, LLC	0%
MILLER WEALTH ADVISORS, LLC	0%

See all

Insights on Kiora Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Kiora Pharmaceuticals, Inc. Common Stock has experienced a drawdown of -60.8%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 39.1%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 40.6%
NEGATIVE IMPACT
Price Dip
In the last 3 years, KPRX stock has moved down by -60.8%

About Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has a strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.

Organisation	Kiora Pharmaceuticals Inc.
Headquarters	332 Encinitas Boulevard, Encinitas, CA, United States, 92024
Industry	Biotechnology
CEO	Dr. Brian M. Strem Ph.D.
E-voting on shares	Click here to vote

Key Management of Kiora Pharmaceuticals Inc.

Name	Title
Dr. Brian M. Strem Ph.D.	President, CEO & Director
Ms. Melissa Tosca CPA	Chief Financial Officer
Dr. Stefan Sperl Ph.D.	Executive Vice President of CMC & Operations

FAQs

What is Kiora Pharmaceuticals Inc. share price today?

Kiora Pharmaceuticals Inc. share price today is $2.53 as on June 19, 2026 at 8:45 am IST at the close of the market. Kiora Pharmaceuticals Inc. share today touched a day high of $2.71 and a low of $2.61.

What is the 52 week high and 52 week low for Kiora Pharmaceuticals Inc. share?

Kiora Pharmaceuticals Inc. share touched a 52 week high of $3.29 on July 18, 2025 and a 52 week low of $1.76 on November 25, 2025. Kiora Pharmaceuticals Inc. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $2.53,which is 23.10% down from its 52 week high and 43.38% up from its 52 week low.

What is Kiora Pharmaceuticals Inc.'s market capitalisation today?

Kiora Pharmaceuticals Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Kiora Pharmaceuticals Inc. Stock (KPRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kiora Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kiora Pharmaceuticals Inc. Shares that will get you 0.5929 shares as per Kiora Pharmaceuticals Inc. share price of $2.53 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Kiora Pharmaceuticals Inc. Stock (KPRX) from India?

Indian investors can start investing in Kiora Pharmaceuticals Inc. (KPRX) shares with as little as ₹94.31 or $1 (as of June 22, 2026 at 5:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Kiora Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on June 22, 2026 at 5:39 am IST). Based on Kiora Pharmaceuticals Inc. share’s latest price of $2.53 as on June 19, 2026 at 8:45 am IST, you will get 3.9526 shares of Kiora Pharmaceuticals Inc.. Learn more about fractional shares .